Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.7772 USD | -2.15% | +2.26% | +5.74% |
2023 | NGM Biopharmaceuticals Says Phase 2b Trial of Potential Cirrhosis Treatment Meets Primary Endpoint | MT |
2023 | Alpine 4 Holdings, Inc.(NasdaqCM:ALPP) dropped from S&P Global BMI Index | CI |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+5.74% | 21.46M | |
+13.33% | 112B | |
+0.17% | 29.94B | |
+13.33% | 22.62B | |
-12.23% | 18.64B | |
-7.29% | 17.49B | |
+17.06% | 16.34B | |
-6.24% | 12.27B | |
+1.93% | 10.8B | |
-10.45% | 9.06B |
- Stock Market
- Equities
- ALPP Stock
- News Alpine 4 Holdings, Inc.
- Alpine 4 Technologies, Ltd. announced a financing transaction